On Thursday, the Food and Drug Administration said Eli Lilly's tirzepatide, sold as Zepbound for weightloss and Mounjaro to treat diabetes, is no longer in short supply. The FDA allows ...
Weightloss varies by individual, but drug study results can give us a general idea. For example, a 2022 study of tirzepatide (the active ingredient in Mounjaro) prescribed for obesity ...
The FDA has not yet approved tirzepatide for weightloss or the management of type 2 diabetes. To approve the generic version of Mounjaro or Zepbound, the FDA will need clear evidence that ...
The weightloss drug Mounjaro costs $1,069 per month if you pay full price or $321 per month if you have insurance coverage. You could pay about $171 per month for Mounjaro if you use a ...